129 related articles for article (PubMed ID: 32917964)
1. Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease.
Zuliani G; Trentini A; Rosta V; Guerrini R; Pacifico S; Bonazzi S; Guiotto A; Passaro A; Seripa D; Valacchi G; Cervellati C
Sci Rep; 2020 Sep; 10(1):14980. PubMed ID: 32917964
[TBL] [Abstract][Full Text] [Related]
2. Serum beta-secretase 1 (BACE1) activity increases in patients with mild cognitive impairment.
Zuliani G; Trentini A; Brombo G; Rosta V; Guasti P; Romagnoli T; Polastri M; Marabini L; Pedrini D; Pistolesi C; Pacifico S; Guerrini R; Seripa D; Cervellati C
J Neurochem; 2021 Nov; 159(3):629-637. PubMed ID: 34534363
[TBL] [Abstract][Full Text] [Related]
3. Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer's disease.
Cervellati C; Trentini A; Rosta V; Passaro A; Bosi C; Sanz JM; Bonazzi S; Pacifico S; Seripa D; Valacchi G; Guerini R; Zuliani G
Geroscience; 2020 Feb; 42(1):159-167. PubMed ID: 31745860
[TBL] [Abstract][Full Text] [Related]
4. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
[TBL] [Abstract][Full Text] [Related]
5. Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease.
Wu G; Sankaranarayanan S; Wong J; Tugusheva K; Michener MS; Shi X; Cook JJ; Simon AJ; Savage MJ
J Neurosci Res; 2012 Dec; 90(12):2247-58. PubMed ID: 22987781
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the Expression of Amyloid Precursor Protein Cleaving Enzymes mRNA in Alzheimer Peripheral Blood.
Wongchitrat P; Pakpian N; Kitidee K; Phopin K; Dharmasaroja PA; Govitrapong P
Curr Alzheimer Res; 2019; 16(1):29-38. PubMed ID: 30411686
[TBL] [Abstract][Full Text] [Related]
7. Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD.
Vergallo A; Houot M; Cavedo E; Lemercier P; Vanmechelen E; De Vos A; Habert MO; Potier MC; Dubois B; Lista S; Hampel H; ;
Alzheimers Dement; 2019 Oct; 15(10):1274-1285. PubMed ID: 31627825
[TBL] [Abstract][Full Text] [Related]
8. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients.
Bram JMF; Talib LL; Joaquim HPG; Sarno TA; Gattaz WF; Forlenza OV
Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):963-972. PubMed ID: 29845446
[TBL] [Abstract][Full Text] [Related]
9. Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia.
Cervellati C; Romani A; Seripa D; Cremonini E; Bosi C; Magon S; Passaro A; Bergamini CM; Pilotto A; Zuliani G
J Neurol Sci; 2014 Feb; 337(1-2):156-61. PubMed ID: 24321755
[TBL] [Abstract][Full Text] [Related]
10. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
[TBL] [Abstract][Full Text] [Related]
11. Uric Acid and High-Density Lipoprotein Cholesterol Are Differently Associated with Alzheimer's Disease and Vascular Dementia.
Liu H; Reynolds GP; Wei X
J Alzheimers Dis; 2020; 73(3):1125-1131. PubMed ID: 31884488
[TBL] [Abstract][Full Text] [Related]
12. The feasibility of utilizing plasma MiRNA107 and BACE1 messenger RNA gene expression for clinical diagnosis of amnestic mild cognitive impairment.
Wang T; Chen K; Li H; Dong S; Su N; Liu Y; Cheng Y; Dai J; Yang C; Xiao S
J Clin Psychiatry; 2015 Feb; 76(2):135-41. PubMed ID: 25742200
[TBL] [Abstract][Full Text] [Related]
13. Camelid heavy chain only antibody fragment domain against β-site of amyloid precursor protein cleaving enzyme 1 inhibits β-secretase activity in vitro and in vivo.
Dorresteijn B; Rotman M; Faber D; Schravesande R; Suidgeest E; van der Weerd L; van der Maarel SM; Verrips CT; El Khattabi M
FEBS J; 2015 Sep; 282(18):3618-31. PubMed ID: 26147692
[TBL] [Abstract][Full Text] [Related]
14. BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R
J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
[TBL] [Abstract][Full Text] [Related]
15. The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
Vassar R
J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789
[TBL] [Abstract][Full Text] [Related]
16. The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia.
Spies PE; Slats D; Sjögren JM; Kremer BP; Verhey FR; Rikkert MG; Verbeek MM
Curr Alzheimer Res; 2010 Aug; 7(5):470-6. PubMed ID: 20043812
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
[TBL] [Abstract][Full Text] [Related]
18. BACE1 and Other Alzheimer's-Related Biomarkers in Cerebrospinal Fluid and Plasma Distinguish Alzheimer's Disease Patients from Cognitively-Impaired Neurosyphilis Patients.
Zhang M; Zhong X; Shi H; Vanmechelen E; De Vos A; Liu S; Chen B; Mai N; Peng Q; Chen X; Wu Z; Hou L; Zhou H; Ouyang C; Zhang W; Liang W; Dai C; Ning Y
J Alzheimers Dis; 2020; 77(1):313-322. PubMed ID: 32804135
[TBL] [Abstract][Full Text] [Related]
19. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.
Zhao J; Fu Y; Yasvoina M; Shao P; Hitt B; O'Connor T; Logan S; Maus E; Citron M; Berry R; Binder L; Vassar R
J Neurosci; 2007 Apr; 27(14):3639-49. PubMed ID: 17409228
[TBL] [Abstract][Full Text] [Related]
20. Plasma viscosity: is a biomarker for the differential diagnosis of Alzheimer's disease and vascular dementia?
Aras S; Tek I; Varli M; Yalcin A; Cengiz OK; Atmis V; Atli T
Am J Alzheimers Dis Other Demen; 2013 Feb; 28(1):62-8. PubMed ID: 23242122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
